Open access journal indexed with Index Medicus
Users online:
13995
Home
|
Reader Login
About
Editorial board
Articles
Current Issue
Ahead of print
Archive
NSI Publications
Current Practice In Neurosciences
Progress In Clinical Neurosciences
Evolution of Neurosciences
Neurosciences India (1989)
Archive
Search
Instructions
Online Submission
Subscribe
Videos
Etcetera
Contact
Navigate
here
»
Search
»
Current Issue
»
Submit Article
»
My Preferences
Follow us on:
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Access statistics : Table of Contents
2014| January-February | Volume 62 | Issue 1
Online since
March 7, 2014
Archives
Previous Issue
Next Issue
Most popular articles
Most cited articles
Show all abstracts
Show selected abstracts
Export selected to
Viewed
PDF
Cited
REVIEW ARTICLE
Stopping antiepileptic drugs in patients with epilepsy in remission: Why, When and How?
Chaturbhuj Rathore, Ross Paterson
January-February 2014, 62(1):3-8
DOI
:10.4103/0028-3886.128224
PMID
:24608446
Making a decision to withdraw antiepileptic drugs (AEDs) in patients with epilepsy in remission requires a careful assessment of many patient and disease related factors and the associated risks and benefits. Although unnecessary continuation of AEDs exposes the patients to unwarranted side-effects, a premature withdrawal with subsequent seizure recurrence may be distressing for the patient who otherwise considers himself as cured. Although the final decision needs to be individualized, there are certain guidelines which can help us in making evidence based decision. In this article, we intend to review the current evidence on this subject with an aim of providing a framework of the best clinical practice in this field.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
12,389
656
6
ORIGINAL ARTICLES
Long-term outcome of decompressive hemicraniectomy in patients with malignant middle cerebral artery infarction: A prospective observational study
Vinod Kumar Rai, Rohit Bhatia, Kameshwar Prasad, MV Padma Srivastava, Shaily Singh, Neha Rai, Ashish Suri
January-February 2014, 62(1):26-31
DOI
:10.4103/0028-3886.128273
PMID
:24608450
Background:
Malignant middle cerebral artery (MCA) infarction is associated with high mortality and morbidity. Decompressive hemicraniectomy (DH) reduces mortality significantly but evidence for long-term functional benefit is sparse and contradictory.
Materials and Methods:
A total of 60 patients with malignant MCA infarction were prospectively enrolled. 36 (60%) patients underwent DH and 24 (40%) patients received best medical therapy alone. Both groups were followed-up for 1 year for improvement in disability and aphasia using modified Rankin score (mRS) and Western Aphasia Battery respectively. Good outcome was defined as mRS ≤ 3. Secondary analysis using mRS ≤ 4 was also performed.
Results:
An absolute risk reduction of 45% was observed in mortality at 1 year; 38% (14/36) in the surgical group died versus 83% (20/24) in the medical group. Good outcome at 1 year was achieved in 20% (7/35) patients in the surgical group compared with none in the medical group (
P
= 0.025). Repeated measures regression suggested increased proportion of patients improving over time (discharge, 3, 6 and 12 months). Surgery reduced the odds of moderate to severe disability (mRS ≥ 4) by 93.5% (odds ratio: 0.064, 95% confidence interval: 0.01-0.045,
P
= 0.006).
Conclusions:
DH in malignant MCA infarction not only reduces mortality but also increases chances of a better functional outcome. The benefit of surgery in motor and aphasia recovery is progressive and sustained until 1 year.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
8,331
297
15
Sulfasalazine and temozolomide with radiation therapy for newly diagnosed glioblastoma
Satoru Takeuchi, Kojiro Wada, Kimihiro Nagatani, Naoki Otani, Hideo Osada, Hiroshi Nawashiro
January-February 2014, 62(1):42-47
DOI
:10.4103/0028-3886.128280
PMID
:24608453
Background:
A recent phase 1/2 clinical trial argued for caution for the use of sulfasalazine in progressive glioblastoma (GBM). However, the study enrolled patients with recurrent or progressive high-grade glioma indicating that patients recruited probably had severe disease. Thus, the study may not accurately reflect the effectiveness of sulfasalazine for GBM and we hypothesized that earlier sulfasalazine administration may lead to anticancer effects.
Aim:
The aim of this study was to investigate whether sulfasalazine can improve the outcomes of patients with newly diagnosed GBM.
Subjects and Methods:
A total of 12 patients were treated with temozolomide and sulfasalazine with radiation therapy after surgery. Twelve patients with primary GBM treated with temozolomide and radiation therapy formed the control group. Progression-free survival (PFS), overall survival (OS) and seizure-free survival (SFS) curves were obtained using the Kaplan-Meier method. The survival curves were compared using the log-rank test.
Results:
The median OS, PFS and SFS did not differ between the groups. Grade 3 or 4 adverse events occurred over the duration of the study in nine (75%) patients. The median SFS was 12 months in nine patients who received sulfasalazine administration for more than 21 days, which was strongly but not significantly longer than the 3 months observed in the control group (P = 0.078).
Conclusions:
Sulfasalazine treatment with temozolomide plus radiotherapy for newly diagnosed primary GBM is associated with a high rate of discontinuation due to hematologic toxic effects. This treatment may have no effect on OS or PFS, although it may improve seizure control if an adequate dose can be administered.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
7,808
124
27
LETTER TO EDITOR
Syphilitic myelitis: Magnetic resonance imaging features
Dongmei He, Binghu Jiang
January-February 2014, 62(1):89-91
DOI
:10.4103/0028-3886.128347
PMID
:24608474
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
6,864
92
12
ORIGINAL ARTICLES
Central nervous system lymphoma: Patterns of incidence in Indian population and effect of steroids on stereotactic biopsy yield
N Manoj, A Arivazhagan, Anita Mahadevan, Dhananjaya I Bhat, HR Arvinda, B Indira Devi, S Sampath, BA Chandramouli
January-February 2014, 62(1):19-25
DOI
:10.4103/0028-3886.128272
PMID
:24608449
Background:
Epidemiology of primary central nervous system lymphoma (PCNSL) world-wide shows an increase in incidence linked to human immunodeficiency virus (HIV) pandemic.
Materials and Methods:
This retrospective review of case records analyzed the trends of hospital-based incidence of PCNSL over two decades (1991-2010), relation to immune status and effect of steroids on yield of stereotactic biopsy (STB).
Results:
A total of 76 cases of PCNSL were diagnosed over a period of two decades. Incidence of lymphomas amongst all biopsied lesions showed a gradual increase from 0.18% at the beginning of study period to 0.41% at the end of study period. Only 8.6% (3 of 35 tested) of the PCNSL patients were positive for HIV. The mean age of patients with HIV infection (31.3 ± 3.5 years) was significantly lower compared with those without HIV infection (44.7 ± 10.9 years) (P = 0.033). Diagnosis was obtained by open biopsy in 32 patients (42.1%) and STB in 44 patients (57.9%). Open biopsy yielded a histological confirmation of PCNSL in all cases. Among those who underwent STB, the incidence of negative biopsy with short duration of steroids (≤1 week) was 33.3% and increased to 57.1% with increasing duration of steroid treatment (>1 week).
Conclusions:
This study documented an increase in hospital based incidence of PCNSL in our institute, independent of HIV association. Steroid intake administration for more than a week prior to biopsy adversely affected the yield of STB in PCNSL.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
6,387
181
18
LETTER TO EDITOR
Anti-GAD negative stiff person syndrome with a favorable response to intravenous methylprednisolone: An experience over evidence
Bhawna Sharma, Kadam Nagpal, Swayam Prakash, Pankaj Gupta
January-February 2014, 62(1):76-77
DOI
:10.4103/0028-3886.128332
PMID
:24608465
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
5,890
91
-
Giant calcified intraventricular pilocytic astrocytoma: A rare entity
Rajinder Kumar, Kanwaljeet Garg, Aanchal Kakkar, Mehar Chand Sharma
January-February 2014, 62(1):71-73
DOI
:10.4103/0028-3886.128326
PMID
:24608462
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
5,804
76
5
ORIGINAL ARTICLES
Fluorescence
in situ
hybridization for 1p, 19q status in a cohort of glial neoplasms
Vandita Y Singh, Geeta Chacko, Ari G Chacko, Vedantam Rajshekhar
January-February 2014, 62(1):32-36
DOI
:10.4103/0028-3886.128275
PMID
:24608451
Objective:
The objective of the following study is to determine 1p, 19q status in a cohort of glial neoplasms.
Materials and Methods:
Fluorescence
in situ
hybridization for determination of 1p, 19q deletions in 100 glial neoplasms diagnosed between January 2007 and March 2011, was performed using Vysis dual color probes localizing to 1p36/1q25; 19q13/19p13.
Results:
Out of the 100 tumors, 78 tumors were either pure oligodendroglial (OD) neoplasms or had an OD component. 1p and 19q codeletions were seen in 72.7% of oligodendrogliomas (World Health Organization [WHO] Grade II), 90.9% of anaplastic oligodendrogliomas (WHO Grade III), 22.2% of mixed oligoastrocytomas (WHO Grade II) and 42.9% of the anaplastic oligoastrocytomas (WHO Grade III). Of the 29 tumors that were diagnosed as glioblastoma multiforme (GBM), 11 had an OD component of which four showed codeletions of 1p and 19q (36.4%) and two tumors showed epidermal growth factor receptor (EGFR) amplification (20%) without 1p19q codeletions. Amongst the remaining 18 GBMs without an OD component, three cases showed EGFR amplification (16.7%), one case showed isolated deletion of 1p and none showed 1p19q codeletions. Polysomies involving 1p and/or 19q with or without deletions were seen in 76.9% of mixed oligoastrocytic tumors, 7.7% of pure OD tumors and one glioblastoma.
Conclusions:
1p19q codeletion is an early molecular change in the genesis of OD tumors, which is retained at the time of progression. Mixed tumors more frequently show polysomies of 1p and 19q. The presence of codeletion in a third of the GBMs with an OD component with its absence in GBMs without an OD component, justifies categorization of these tumors as a separate entity.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
5,543
140
1
Sonothrombolysis in acute middle cerebral artery stroke
Amira Zaki Dwedar, Samia Ashour, Mahmoud Haroun, Azza Abd El Nasser, Ramez Reda Moustafa, Mohamed Hamdy Ibrahim, Ahmed Elsadek
January-February 2014, 62(1):62-65
DOI
:10.4103/0028-3886.128308
PMID
:24608457
Objectives:
The objective of the following study is to determine the effect of continuous insonation using 2-MHz transcranial Doppler-ultrasound (TCD-US) on the recanalization rate and the short-term outcome in subjects with acute ischemic stroke due to middle cerebral artery (MCA) occlusion.
Materials and Methods:
A total of 42 patients with acute ischemic stroke due to MCA occlusion within 24 h were recruited and randomly allotted to two groups (21 patients in each group). Group 1 included patients who received 1 h continuous TCD-US for MCA and Group 2 included patients who did not receive 1 h continuous TCD-US. Patients in both groups were received MCA insonation and TCD study to measure mean flow velocity (MFV) in MCA one after the initial study at 20 and 60 min. All patients received aspirin (150-325 mg). The clinical course during hospital stay was assessed before and after 1 h of US insonation, at 24 h after symptom onset using the National Institutes of Health Stroke Scale.
Results:
Change in MFV after insonation for Group 1 in comparison to Group 2 at 3 time points was significantly high (
P
< 0.001).
Conclusion:
Sonothrombolysis is a therapeutic option to improve the outcomes in patients with acute ischemic stroke due to MCA occlusion.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
5,539
142
1
A Markov model to compare the long-term effect of aspirin, clopidogrel and clopidogrel plus aspirin on prevention of recurrent ischemic stroke due to intracranial artery stenosis
Jinqiu Yang, Lukui Chen, Naveen Chitkara, Qiang Xu
January-February 2014, 62(1):48-52
DOI
:10.4103/0028-3886.128290
PMID
:24608454
Background:
Given the importance of intracranial stenosis as a cause of recurrent ischemic stroke and the lack of evidence supporting a clear choice for prevention of recurrent ischemic events, a computer simulation model for prognostic prediction could be used to improve decision making.
Aims:
The aim of the following study is to compare the long-term effect of aspirin, clopidogrel and clopidogrel plus aspirin for prevention of recurrent stroke due to atherosclerotic intracranial artery stenosis.
Setting and Design:
The cohort consisted of 206 patients from 2006 to 2011.
Materials and Methods:
A two-state Markov model was used to predict the prognosis of patients with stroke or transient ischemic attack (TIA) caused by angiographically verified 50-99% stenosis of a major intracranial artery to receive aspirin, clopidogrel, or dual therapy.
Statistical Analysis:
Two tests were used: Pearson Chi-square test or Fisher's exact test (for percentages) and Kruskal Wallis test (for rank order data).
Results:
In the 10-year Markov cohort analysis, 36.24% of patients who were treated with clopidogrel plus aspirin developed to recurrent stroke while the probability for patients in the aspirin group and clopidogrel group was 42.60% and 48.39% respectively. Patients with clopidogrel plus aspirin had the highest quality-adjusted life years, followed by aspirin and clopidogrel.
Conclusion:
To prevent recurrent stroke in patients with intracranial artery stenosis, especially in those patients with a history of TIA or coronary artery disease, medical therapy with clopidogrel plus aspirin should be considered in preference to aspirin alone.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
5,459
101
4
LETTER TO EDITOR
Inclusion body myositis involving the diaphragm: Report of a pathologically confirmed case
Sarah E Martin, Dibson D Gondim, Eyas M Hattab
January-February 2014, 62(1):66-67
DOI
:10.4103/0028-3886.128313
PMID
:24608458
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
5,420
54
3
ORIGINAL ARTICLES
Long-term outcomes of trapping vertebral artery-posterior inferior cerebellar artery dissecting aneurysms after revascularization
Chongqian Wang, Xiang-En Shi, Jinkun Wang, Bo Wang, Zhiwei Tang
January-February 2014, 62(1):15-18
DOI
:10.4103/0028-3886.128247
PMID
:24608448
Objective:
This study is designed to evaluate the long-term outcome of trapping vertebral artery-posterior inferior cerebellar artery (VA-PICA) dissecting aneurysms after revascularization.
Materials and Methods:
Five patients with VA-PICA dissecting aneurysms were treated surgically between 2007 and 2010. All the aneurysms were trapped through a far-lateral approach after revascularization of the PICAs by occipital artery-posterior inferior cerebellar artery (OA-PICA) bypass. All patients were scheduled for clinical follow-up in the out-patient department at 3 months, 6 months, then annually. Computed tomography (CT) scan and CT angiography, or magnetic resonance (MR) imaging and MR angiography were performed to assess the anastomosis and cerebral blood supply.
Results:
Among the five patients, two of them did not have any neurological deficit after surgery, the other three had post-operative lower cranial nerve palsy but recovered completely within 6 months. Post-operative cerebral angiography (received by two patients) and CT angiography (received by the other three patients) showed patent bypasses in all patients and there was no reappearance of the aneurysms. After following-up from 47 to 74 months (61 month is the median follow-up period), all patients showed excellent outcomes.
Conclusion:
Trapping the aneurysms after revascularization of PICAs by OA-PICA bypass is a safe method to treat the VA-PICA dissecting aneurysms.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
5,393
64
5
LETTER TO EDITOR
Acute transverse myelitis: A rare neurological complication following wasp sting
Kolar Vishwanath Vinod, Madasamy Ponraj, Khened Swetharani, Tarun Kumar Dutta
January-February 2014, 62(1):88-89
DOI
:10.4103/0028-3886.128346
PMID
:24608473
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
5,379
64
-
Paradoxical herniation caused by cerebrospinal fluid drainage after decompressive craniectomy
Qiang-ping Wang, Zhang-ming Zhou, Chao You
January-February 2014, 62(1):79-80
DOI
:10.4103/0028-3886.128337
PMID
:24608467
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
5,180
70
8
Polymyositis with myotonia in a patient with common variable immunodefi ciency
Ying Li, Wei Zhang, LQ Feng, Yun Yuan
January-February 2014, 62(1):68-70
DOI
:10.4103/0028-3886.128315
PMID
:24608460
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
5,124
51
-
Peripheral nerves and muscles involvement by non-Hodgkin's lymphoma seen on FDG PET/CT scan
Hina J Shah, Vikram R Lele, Abhishek R Keraliya, Parag S Aland
January-February 2014, 62(1):83-85
DOI
:10.4103/0028-3886.128341
PMID
:24608470
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
5,098
69
3
A rare case of Guillain-Barre syndrome following scrub typhus
Vishal M Sawale, Sanjay Upreti, Th. Suraj Singh, N Biplab Singh, Th. Bhimo Singh
January-February 2014, 62(1):82-83
DOI
:10.4103/0028-3886.128340
PMID
:24608469
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
4,743
165
9
NEUROIMAGES
Heart appearance sign in pontine stroke: A result of bilateral infarction due to small vessel disease
Prasanna Venkatesan, R Balakrishnan, K Ramadoss, Rajesh Shankar Iyer
January-February 2014, 62(1):115-116
DOI
:10.4103/0028-3886.128365
PMID
:24608490
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
4,700
105
5
LETTER TO EDITOR
Sixth nerve schwannoma
Rajinder Kumar, Anil Kothiwala, Ranajoy Ghosh
January-February 2014, 62(1):99-100
DOI
:10.4103/0028-3886.128355
PMID
:24608481
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
4,693
67
3
EDITORIAL
Neurological and neuroimaging signs of reversible Parkinsonism associated with manganese exposure
Basant K Puri
January-February 2014, 62(1):1-2
DOI
:10.4103/0028-3886.128210
PMID
:24608445
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
4,589
145
2
LETTER TO EDITOR
Extracranial infrasellar craniopharyngioma
Hari Nivas Periyakottai Senthilvel, Shyam Sundar Krishnan, Madabhushi Chakravarthy Vasudevan
January-February 2014, 62(1):100-103
DOI
:10.4103/0028-3886.128356
PMID
:24608482
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
4,644
71
5
ORIGINAL ARTICLES
Relative quantitative expression of hypoxia-inducible factor 1 alpha messenger ribonucleic acid in recurrent craniopharyngiomas
Hao Liu, Zhiyong Liu, Jin Li, Qiang Li, Chao You, Jianguo Xu
January-February 2014, 62(1):53-56
DOI
:10.4103/0028-3886.128291
PMID
:24608455
Background:
Craniopharyngioma is a benign tumor, but recurrences are common and prognosis is poor. The pathologic mechanism underlying the high recurrence is still unknown.
Aims:
We hypothesized that there are hypoxic microenvironments within craniopharyngiomas and hypoxia inducible factor-1 alpha (HIF-1α) and its related genes are largely expressed in recurrent craniopharyngiomas.
Materials and Methods:
A total of 19 patients with craniopharyngiomas have been identified. The relative quantitative expressions of HIF-1α, vascular endothelial growth factor (VEGF) and carbonic adhydrase 9 (CA9) messenger ribonucleic acid (mRNA) of craniopharyngioma tissues were detected by real time reverse transcription polymerase chain reaction.
Results:
HIF-1α and VEGF mRNA was significantly up-regulated in recurrent craniopharyngiomas. Mean expression levels (recurrent craniopharyngiomas compared with non-recurrent craniopharyngiomas, as normalized to expression of β-actin) were 3.09 versus 0.75 (P = 0.001) for HIF-1α, 1.07 versus 0.32 (P = 0.000) for VEGF, 1.21 versus 1.93 (P = 0.503) for CA9. In craniopharyngiomas, the expression of VEGF showed a significant correlation with HIF-1α (r = 0.836, P = 0.000).
Conclusion:
There were hypoxic microenvironments within craniopharyngiomas. Therefore, preventing the tumor cells from adapting to the hypoxic conditions may be an effective way to obviate the relapse of craniopharyngioma.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
4,639
54
7
LETTER TO EDITOR
Rapidly progressive dementia, Parkinsonism and myoclonus: An unusual presentation of dural arteriovenous fistula
Sujit Abajirao Jagtap, Sruthi S Nair, Narendra Jain, MD Nair
January-February 2014, 62(1):107-110
DOI
:10.4103/0028-3886.128360
PMID
:24608486
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
4,517
82
5
ORIGINAL ARTICLES
Assessment of expression of epidermal growth factor receptor and p53 in meningiomas
Swetha Narla, Megha S Uppin, M Vijaya Saradhi, BP Sahu, AK Purohit, C Sundaram
January-February 2014, 62(1):37-41
DOI
:10.4103/0028-3886.128276
PMID
:24608452
Background:
Meningiomas represent about 30% of primary adult central nervous system tumors. Though slow growing, they recur, causing significant morbidity and mortality.
Objective:
The objective of the following study is to grade meningiomas according to World Health Organization (WHO) 2007 criteria and to correlate the grade with degree of expression of epidermal growth factor receptor (EGFR) and p53.
Materials and Methods:
Meningiomas diagnosed in the year 2010 in the Department of Pathology of our institute, were included in the study. Clinical and radiological findings were noted from medical records. The histopathology slides were reviewed and the tumors were graded according to WHO 2007 criteria. Tissue microarrays (TMA) were prepared and immunohistochemical analysis with epithelial membrane antigen, Vimentin, Ki67, EGFR and p53 was performed on the TMA slides.
Results:
A total of 79 meningiomas diagnosed during the study period included 30 male and 49 female patients with an age range of 10-75 years. There was a female preponderance with M:F ratio of 1:1.63. EGFR was found to be higher in grade I (82.93%) compared with grade II (35.71%) and grade III tumors (20%) with an overall positivity of 60.81%. Mean p53 indices were higher in grade III (50%) compared with grade II (39.29%) and grade I tumors (38.46%) with an overall positivity of 39.44%. Ki67 labeling index (LI) was significantly high in grade III (16.4%) compared with grade II (6.46%) and grade I tumors (3.13%).
Conclusion:
EGFR expression and Ki67 LI correlated with grade of meningioma
P
< 0.0001 and
P
< 0.0001 respectively which were statistically significant whereas p53 expression did not correlate (
P
- 0.90).
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
4,439
103
8
Investigation of the Rho-kinase 2 gene Thr431Asn polymorphism in migraine
Samiye Uslu Kuzudisli, Mustafa Yilmaz, Zeynep Gül, Seniz Demiryürek, Remzi Yigiter, Hakan Bozkurt, Aylin Akcali, Münife Neyal, Cahit Bagci, Beyhan Cengiz, Serdar Öztuzcu, Abdullah T Demiryürek
January-February 2014, 62(1):9-14
DOI
:10.4103/0028-3886.128241
PMID
:24608447
Background:
Migraine has a complex etiology determined by genetic and environmental factors, but the molecular mechanisms and genetics of this disease have not yet been fully clarified.
Aim:
This case/control study was designed to analyze the genotype distributions and allele frequencies for the Rho-kinase 2 (ROCK2) gene Thr431Asn polymorphism among the migraine patients.
Materials and Methods:
A total of 155 migraine patients and 155 healthy age and sex matched controls were included in this study. Genomic deoxyribonucleic acid from migraine patients and controls was analyzed by real-time polymerase chain reaction.
Results:
Neither genotype distributions nor the allele frequencies for the Thr431Asn polymorphism showed a significant difference between the groups. In addition, there were no marked differences in genotype and allele frequencies for the migraine without aura and migraine with aura subgroups when compared with control group.
Conclusion:
This is the first study to show that the
ROCK
2 gene Thr431Asn polymorphism is not a risk factor for the migraine in the Turkish population.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
4,379
86
-
LETTER TO EDITOR
An unusual case of reversible cerebral vasoconstriction syndrome presenting during antepartum period
Amita Bhargava, Basavaraj F Banakar, Guruprasad S Pujar, K Shubhkaran, Hemant Jangid
January-February 2014, 62(1):91-92
DOI
:10.4103/0028-3886.128349
PMID
:24608475
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
4,345
83
1
Diaphragma sella meningioma presenting with posterior cerebral artery infarct: Case report and review of literature
Rakshith Shetty, Raman Mohan Sharma, Paritosh Pandey
January-February 2014, 62(1):77-78
DOI
:10.4103/0028-3886.128335
PMID
:24608466
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
4,331
69
1
ORIGINAL ARTICLES
The expression of disabled-2 is common reduced in meningiomas
Ziyin Zhang, Yihua Chen, Xuemei Xie, JianJian Tang
January-February 2014, 62(1):57-61
DOI
:10.4103/0028-3886.128299
PMID
:24608456
Aims:
Disabled-2 (Dab2) is frequently down-regulated in several types of cancers. We examined the expression level of Dab2 in human meningiomas and meningioma cells, aimed to investigate its role in the oncogenesis and development of meningiomas.
Materials and Methods:
Western blot analysis was employed to detect Dab2 expression in 90 fresh tissues of meningiomas, 10 leptomeninges and two kinds of human malignant meningioma cell lines. Independent samples t-test, analysis of variance, Pearson Chi-square test and likelihood ratio test were used to analyze the expression level of Dab2 and its relations to clinic-pathological characteristics of meningiomas.
Results:
Dab2 was significantly down-regulated in classic meningiomas than the atypical or anaplastic meningiomas. The reduced or loss of expression of Dab2 were significantly correlated with the lower classification of meningiomas and negatively correlated with the invasive ability of adjacent tissues. Furthermore, it was reduced or lost in malignant meningioma cell lines (IOMM-Lee and KT21-MG1). The lower classification of meningiomas correlated with previous comorbidities; not with the gender, age of patients and smoking.
Conclusions:
Dab2 is expressed at variable level in meningiomas with different grade of malignancy and probably plays a pivotal role in the early stage of oncogenesis of malignant meningiomas.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
4,194
59
3
LETTER TO EDITOR
Third ventricular tuberculoma
Kanwaljeet Garg, Hitesh Kumar Gurjar, S Gurjar Joseph, Ravi Chetan Shashikant, Bhawani Shankar Sharma
January-February 2014, 62(1):73-75
DOI
:10.4103/0028-3886.128329
PMID
:24608463
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
4,148
96
3
NEUROIMAGES
Missing trigeminal nerve found in trigeminal neuralgia
Prashant S Naphade, Abhishek R Keraliya
January-February 2014, 62(1):112-112
DOI
:10.4103/0028-3886.128364
PMID
:24608488
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
4,050
80
2
LETTER TO EDITOR
Intrasellar cavernous hemangioma
LC Ma, WY Li, WQ Chen, YK Wu
January-February 2014, 62(1):95-96
DOI
:10.4103/0028-3886.128352
PMID
:24608478
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
3,940
55
3
Isolated metastasis of breast cancer to the pituitary gland
Murat Sakir Eksi, Teyyub Hasanov, Baran Yilmaz, Akin Akakin, Yasar Bayri, Suheyla Uyar Bozkurt, Türker Kiliç
January-February 2014, 62(1):70-71
DOI
:10.4103/0028-3886.128322
PMID
:24608461
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
3,879
57
6
Schwannoma of supraorbital nerve presenting as a subfrontal tumor
Ari George Chacko, Manikandan S Natarajan, Krishna Prabhu, Geeta Chacko
January-February 2014, 62(1):96-98
DOI
:10.4103/0028-3886.128353
PMID
:24608479
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
3,774
58
1
A case of frontal lobe infarct in
Plasmodium vivax
infection
OP Jatav, Ashish Singhal, Ajay Pal Singh
January-February 2014, 62(1):67-68
DOI
:10.4103/0028-3886.128314
PMID
:24608459
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
3,662
83
-
Intravenous immunoglobulin induced meningoencephalitis
Javeria Nooraine, Rajesh B Iyer, S Raghavendra
January-February 2014, 62(1):98-99
DOI
:10.4103/0028-3886.128354
PMID
:24608480
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
3,533
75
1
Calcified cavernous malformation of the lower cranial nerves
Bijesh Ravindran Nair, Krishna Prabhu, Geeta Chacko, Ari George Chacko
January-February 2014, 62(1):104-105
DOI
:10.4103/0028-3886.128358
PMID
:24608484
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
3,538
50
2
Dengue hemorrhagic fever: A rare cause of pituitary apoplexy
Sudhansu Sekhar Mishra, Souvagya Panigrahi, Srikanta Das
January-February 2014, 62(1):92-93
DOI
:10.4103/0028-3886.128350
PMID
:24608476
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
3,505
80
4
Mickey Mouse aneurysms: A rare case of bilateral superior cerebellar artery origin aneurysms
Ankush Gupta, Bijesh R Nair, Vivek Joseph
January-February 2014, 62(1):75-76
DOI
:10.4103/0028-3886.128331
PMID
:24608464
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
3,457
68
-
A rare case of carcinoma rectum metastasing to clivus
Bhaskar Kendre, Chandrashekhar Deopujari, Vikram Karmarkar, Vishwaraj Ratha
January-February 2014, 62(1):85-86
DOI
:10.4103/0028-3886.128343
PMID
:24608471
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
3,408
78
3
NEUROIMAGES
Dumbbell shaped spinal hydatidosis
Krishna Chaitanya Joshi, Aniruddh T Jagannath, Ravi Gopal Varma
January-February 2014, 62(1):113-114
DOI
:10.4103/0028-3886.128363
PMID
:24608489
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
3,365
68
3
Reversal of pallidal magnetic resonance imaging T1 hyperintensity in a welder presenting as reversible Parkinsonism
Su-Hyun Han, Suk-Won Ahn, Young C Youn, Hae-Won Shin
January-February 2014, 62(1):117-118
DOI
:10.4103/0028-3886.128366
PMID
:24608491
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
3,303
50
3
LETTER TO EDITOR
An interesting lesion: Solitary extra ventricular sub-ependymal giant cell astrocytomas
Jasmit Singh, Hrushikesh Kharosekar, Vernon Velho
January-February 2014, 62(1):94-95
DOI
:10.4103/0028-3886.128351
PMID
:24608477
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
3,285
58
-
Multiple nocardial cerebral abscesses in a patient with pulmonary aspergillosis
Prasad Krishnan, Rohit Mishra, Rajaraman Kartikueyan, Eswara Rao Thamatapu
January-February 2014, 62(1):105-107
DOI
:10.4103/0028-3886.128359
PMID
:24608485
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
3,151
74
-
Large unruptured proximal (A1) anterior cerebral artery aneurysm with aplasia of the contralateral A1
Ananthan Raghothaman, Lekha Pandit
January-February 2014, 62(1):80-82
DOI
:10.4103/0028-3886.128339
PMID
:24608468
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
3,116
69
-
Anterior third ventricular epidermoid presenting with diabetes insipidus
Amandeep Kumar, Raghav Singla, Bhawani S Sharma
January-February 2014, 62(1):86-88
DOI
:10.4103/0028-3886.128345
PMID
:24608472
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
2,946
77
2
Pearly encirclement of the brainstem
Raghvendra Ramdasi, Aadil Chagla, Amit Mahore
January-February 2014, 62(1):103-104
DOI
:10.4103/0028-3886.128357
PMID
:24608483
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
2,624
69
-
CORRESPONDENCE
Comment on: Neurocysticercosis presenting as Parkinsonism
Beuy Joob, Viroj Wiwanitkit
January-February 2014, 62(1):110-110
DOI
:10.4103/0028-3886.128361
PMID
:24608487
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
2,602
82
-
Authors' Reply
Rohit Verma, Kuljeet Singh Anand, BB Sharma, Jyoti Garg
January-February 2014, 62(1):110-111
DOI
:10.4103/0028-3886.128362
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
2,500
44
2
Site Map
|
Home
|
Contact Us
|
Advertise With Us
|
Feedback
|
Copyright and Disclaimer
|
Privacy Notice
Online since 20
th
March '04
Published by Wolters Kluwer -
Medknow
Cookie Settings